ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Previous studies have shown that the serum levels of adiponectin are reduced in NASH patients (31), and hypoadiponectinemia is negatively associated with steatosis and inflammation in NAFLD patients (32).